Rethink of EGFR in Cancer With Its Kinase Independent Function on Board

por Thomas, Rintu, Weihua, Zhang
Publicado 2019

Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors

por Thomas, Rintu, Srivastava, Shivangi, Katreddy, Rajasekhara Reddy, Sobieski, Jason, Weihua, Zhang
Publicado 2019

Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation

por Bollu, Lakshmi Reddy, Katreddy, Rajashekhara Reddy, Blessing, Alicia Marie, Pham, Nguyen, Zheng, Baohui, Wu, Xu, Weihua, Zhang
Publicado 2015

Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt

por Katreddy, Rajasekhara Reddy, Bollu, Lakshmi Reddy, Su, Fei, Xian, Na, Srivastava, Shivangi, Thomas, Rintu, Dai, Yubing, Wu, Bing, Xu, Yunlu, Rea, Michael A., Briggs, James M., Zhang, Qingyuan, Lu, Xiongbin, Huang, Gangxiong, Weihua, Zhang
Publicado 2018

PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs

por Chen, Chia-Hung, Wang, Bo-Wei, Hsiao, Yu-Chun, Wu, Chun-Yi, Cheng, Fang-Ju, Hsia, Te-Chun, Chen, Chih-Yi, Wang, Yihua, Weihua, Zhang, Chou, Ruey-Hwang, Tang, Chih-Hsin, Chen, Yun-Ju, Wei, Ya-Ling, Hsu, Jennifer L., Tu, Chih-Yen, Hung, Mien-Chie, Huang, Wei-Chien
Publicado 2021